Polyglucose dialysis solution induces changes in blood chemistry.

Area of Science:

• Nephrology
• Biochemistry
• Medical Technology

Background:

• Peritoneal dialysis (PD) is a crucial renal replacement therapy.
• Dialysis solutions can impact patient biochemistry.
• Polyg glucose dialysis solution (PG-DS) is used in PD, but its biochemical effects require detailed study.

Purpose of the Study:

• To investigate the effects of PG-DS on serum levels of various biochemical parameters in continuous ambulatory peritoneal dialysis (CAPD) patients.
• To assess changes in electrolytes, waste products, protein, lipids, and acid-base status during and after PG-DS treatment.

Main Methods:

• A longitudinal study involving 14 CAPD patients using 7.5% PG-DS for overnight exchanges.
• Blood samples were collected and analyzed at multiple time points: before PG-DS, during PG-DS treatment (short-term and long-term), and after discontinuation.
• Key parameters measured included electrolytes (Na+, K+, Ca++), urea nitrogen, creatinine, uric acid, total protein, albumin, intact parathyroid hormone (iPTH), lipid profile, and acid-base status.

Main Results:

• Significant changes were observed in sodium, potassium, total calcium, urea nitrogen, creatinine, uric acid, and total protein levels during long-term PG-DS administration compared to baseline.
• Serum lipid levels remained stable during PG-DS treatment but increased upon discontinuation.
• Most other biochemical parameters returned to pre-treatment levels after discontinuing PG-DS.

Conclusions:

• PG-DS demonstrably influences blood chemistry in CAPD patients.
• Observed biochemical alterations, though not requiring clinical intervention in this cohort, necessitate careful clinical analysis and monitoring.
• Further research is recommended to fully understand the clinical implications of these PG-DS-induced biochemical changes.